AbbVie Accumulated Other Comprehensive Income from 2010 to 2025

ABBV Stock  USD 203.01  1.13  0.55%   
AbbVie Accumulated Other Comprehensive Income yearly trend continues to be fairly stable with very little volatility. Accumulated Other Comprehensive Income will likely drop to about -2 B in 2025. Accumulated Other Comprehensive Income is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. View All Fundamentals
 
Accumulated Other Comprehensive Income  
First Reported
2011-12-31
Previous Quarter
-2.3 B
Current Value
-1.9 B
Quarterly Volatility
B
 
Yuan Drop
 
Covid
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.8 B, Interest Expense of 2.9 B or Selling General Administrative of 8.3 B, as well as many indicators such as Price To Sales Ratio of 3.46, Dividend Yield of 0.0288 or PTB Ratio of 99.06. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Accumulated Other Comprehensive Income Growth Pattern

Below is the plot of the Accumulated Other Comprehensive Income of AbbVie Inc over the last few years. It is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. AbbVie's Accumulated Other Comprehensive Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
Accumulated Other Comprehensive Income10 Years Trend
Slightly volatile
   Accumulated Other Comprehensive Income   
       Timeline  

AbbVie Accumulated Other Comprehensive Income Regression Statistics

Arithmetic Mean(1,936,007,938)
Coefficient Of Variation(60.21)
Mean Deviation903,270,336
Median(2,199,000,000)
Standard Deviation1,165,629,892
Sample Variance1358693T
Range3.9B
R-Value(0.65)
Mean Square Error839753T
R-Squared0.42
Significance0.01
Slope(159,261,657)
Total Sum of Squares20380395.7T

AbbVie Accumulated Other Comprehensive Income History

2025-2 B
2024-1.9 B
2023-2.3 B
2022-2.2 B
2021-2.9 B
2020-3.1 B
2019-3.6 B

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's Accumulated Other Comprehensive Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-1.9 B-2 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.